Development of Federally Mandated Risk Evaluation and Mitigation Strategies (REMS) for Transmucosal Immediate-Release Fentanyl Products

Những quyển sách tương tự

• Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl Products
  Bằng: Rollman, Jeffrey Eric, et al.
  Được phát hành: (2019)
• Association of a Risk Evaluation and Mitigation Strategy Program With Transmucosal Fentanyl Prescribing
  Bằng: Fleischman, William, et al.
  Được phát hành: (2019)
• Safety and Efficacy of Oral Transmucosal Fentanyl Citrate Compared to Morphine Sulphate Immediate Release Tablet in Management of Breakthrough Cancer Pain
  Bằng: Bhatnagar, Sushma, et al.
  Được phát hành: (2014)
• The changing landscape of opioid prescribing: long-acting and extended-release opioid class-wide Risk Evaluation and Mitigation Strategy
  Bằng: Gudin, Jeffrey A
  Được phát hành: (2012)
• Characteristics of Analgesic Patch Formulations
  Bằng: Nalamachu, Srinivas, et al.
  Được phát hành: (2020)